- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03283345
Effect of Menstrual Cycle on Traumatic Systemic Response
September 15, 2017 updated by: Hayal Uzelli Şimşek, Kocaeli University
ASSESSMENT OF SYSTEMIC RESPONSES TO TRAUMA IN DIFFERENT PHASES OF THE MENSTRUAL CYCLE: IN PATIENTS UNDERWENT MODIFIED RADICAL MASTECTOMY A Clinical Study
It is aimed to evaluate pathophysiology of systemic responses to trauma via using interleukin (IL) -1 and IL-6 levels and determining timing of surgery through phases of menstrual cycle.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
89 female breast cancer patient who underwent modified radical mastectomy included into study.
Menstrual history and hormone levels were used to determine menstrual phase: luteal, follicular, and other.
IL-1β and IL-6 levels, which are related to severeness of inflammation, were measured one day before and one day after surgery.
Those are statistically analysed to show effect of timing of breast surgery on responses to trauma in postmenopausal and premenopausal women during different phases of their menstrual cycles
Study Type
Interventional
Enrollment (Actual)
89
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- female patients
- who underwent modified radical mastectomy for breast cancer
- who signed informed consent forms
Exclusion Criteria:
- For premenopausal patients taking oral contraceptives
- for postmenopausal patients taking hormone replacement therapy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: postmenopausal women
postmenopausal female breast cancer patients who underwent modified radical mastectomy
|
systemic responses to trauma are compared with evaluating inflammatory cytokine levels between premenopausal and postmenopausal patient groups with different estrogen levels who underwent modified radical mastectomy.
|
Active Comparator: premenopausal women
premenopausal female breast cancer patients who underwent modified radical mastectomy
|
systemic responses to trauma are compared with evaluating inflammatory cytokine levels between premenopausal and postmenopausal patient groups with different estrogen levels who underwent modified radical mastectomy.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
IL-1 and IL-6 levels
Time Frame: 5 month
|
evaluate pathophysiology of systemic responses to trauma via using IL-1 and IL-6 levels.
|
5 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Cantürk, Kocaeli University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2008
Primary Completion (Anticipated)
November 1, 2018
Study Completion (Anticipated)
November 1, 2018
Study Registration Dates
First Submitted
August 20, 2017
First Submitted That Met QC Criteria
September 12, 2017
First Posted (Actual)
September 14, 2017
Study Record Updates
Last Update Posted (Actual)
September 18, 2017
Last Update Submitted That Met QC Criteria
September 15, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2008/69
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Systemic Inflammatory Response Syndrome
-
University of CologneCompletedSystemic Inflammatory Response Syndrome (SIRS)Germany
-
Arkansas Children's Hospital Research InstituteEunice Kennedy Shriver National Institute of Child Health and Human Development...TerminatedSIRS (Systemic Inflammatory Response Syndrome(United States
-
Medical University of GdanskCompletedInflammatory Response Syndrome, Systemic | Granulocyte Immature FormsPoland
-
Chinese PLA General HospitalCompletedSepsis | SIRS(Systemic Inflammatory Response Syndrome)China
-
Chinese PLA General HospitalUnknownSepsis | SIRS(Systemic Inflammatory Response Syndrome)China
-
ImmunexpressJohns Hopkins University; Northwell Health; Rush University Medical Center; Intermountain... and other collaboratorsCompletedSepsis | Systemic Inflammatory Response Syndrome (SIRS)United States
-
Seattle Children's HospitalImmunexpressCompletedSepsis | Systemic Inflammatory Response Syndrome (SIRS)United States
-
University of ArkansasTerminatedPediatric Patients With SIRS (Systemic Inflammatory Response Syndrome)United States
-
University Hospital, LimogesTerminatedSevere Sepsis | Inflammatory Response Syndrome, SystemicFrance
-
Seattle Children's HospitalImmunexpressCompletedSepsis | Non-Infectious Systemic Inflammatory Response SyndromeUnited States
Clinical Trials on modified radical mastectomy
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingInflammatory Breast CancerItaly
-
Mansoura UniversityMansoura University HospitalActive, not recruiting
-
Marshall UniversityZimmer Biomet; Cabell Huntington HospitalUnknownMastectomyUnited States
-
Shengjing HospitalRecruiting
-
Istanbul UniversityCompleted
-
Peking Union Medical College HospitalRecruiting
-
First Affiliated Hospital Xi'an Jiaotong UniversityUnknown
-
South Egypt Cancer InstituteEnrolling by invitationPain, PostoperativeEgypt
-
Hospital de Câncer de PernambucoProfessor Fernando Figueira Integral Medicine Institute; Santa Casa de Misericórdia...CompletedUterine Cervical Neoplasms
-
Shandong UniversityCompletedImage Quality | Mucosal IrritationChina